(Updated - August 29, 2022 7:27 AM EDT)

Argus analyst John Eade upgraded AstraZeneca (NASDAQ: AZN) from Hold to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE